Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicament for treating cerebrovascular and cardiovascular disease and apoplexy sequelae

A technology for sequelae of stroke and cardiovascular and cerebrovascular diseases, applied in the fields of cardiovascular system diseases, drug combinations, and medical formulas, which can solve problems such as easy recurrence, unstable condition, failure to remove thrombus, and dilate blood vessels

Inactive Publication Date: 2007-05-23
李文杰
View PDF0 Cites 21 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Therefore, insufficient cardiovascular and cerebrovascular blood flow and blocked blood vessels are likely to cause sequelae such as stroke, hemorrhage, and thrombus; existing treatments for cardiovascular and cerebrovascular diseases and sequelae of stroke only use compound salvia miltiorrhiza needles and a small amount of western medicine alone, and long-term infusion and long-term use Antihypertensive and blood lipid-lowering drugs only lower blood pressure and relieve heart function, and the cost is high, the condition is unstable, and it is easy to relapse; for cardiovascular and cerebrovascular diseases, stroke sequelae, cerebral thrombosis and other diseases, it cannot remove blood clots and dilate blood vessels. It does not have a good circulation effect on invigorating qi and blood, promoting essence and body fluid, and lowering blood lipids. The treatment effect is not good, and the treatment cycle is long; however, the curative effect is still unsatisfactory

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0017] The medicine of the present invention is mainly made of the following raw materials by weight: Angelica sinensis (酒浸) 7.5 parts, white ginseng 4.5 parts, Chuanxiong 7.5 parts, Chuan Wu (制) 4.5 parts, Aconitum (制) 4.5 parts, 6 parts of white poria cocos, 7.5 parts of angelica dahurica, white snake (沙炒酒浸) 15 copies, herb (米泔洗) 6 servings, licorice (蜜灸) 30 servings, silkworm (炒) 7.5 parts, Liao Asarum 6 parts, Fangfeng 6 parts, Schizonepeta 6 parts, two pointed (酒浸) 3 parts, 9 parts ephedra, 9 parts artemisinin, dendrobium ( 酒洗) 20 servings, whole worm (焙干) 7.5 parts, Gastrodia elata 7.5 parts, Danshen 30 parts, Polygonum multiflorum (黑豆水蒸) 15 parts, 10 parts of Tianqi, 60 parts of Astragalus, 20 parts of Rehmannia glutinosa, 15 parts of Rehmannia glutinosa, 7.5 parts of red peony, 7.5 parts of safflower, peach kernel (去皮) 7.5 parts, 3 parts centipede, 4 parts tender antler, 4 parts gecko, earth dragon (酒浸) 9 parts, Tu Yuan (制) 12 parts, Eucommia (炒) 12 servings...

Embodiment 2

[0019] The medicine of the present invention is mainly made of the following raw materials by weight: Angelica sinensis (酒浸) 7.5 parts, white ginseng 9.5 parts, Chuanxiong 12 parts, Chuan Wu (制) 4.5 parts, Aconitum (制) 4.5 parts, 9 parts of white poria cocos, 9 parts of angelica dahurica, white snake (沙炒酒浸) 15 copies, herb (米泔洗) 6 servings, licorice (蜜灸) 45 servings, silkworm (炒) 10.5 parts, Liao Asarum 7.5 parts, Fangfeng 9 parts, Nepeta 9 parts, two sharp (酒浸) 6 parts, Ephedra 9 parts, Artemisia benzene 9 parts, Dendrobium (酒洗) 15 servings, whole worm (焙干) 9 parts, Gastrodia 9 parts, Salvia 24 parts, Polygonum multiflorum (黑豆水蒸) 12 parts, 9 parts Tianqi, 30 parts Astragalus, 24 parts Rehmannia glutinosa, 12 parts Rehmannia glutinosa, 15 parts red peony, 9 parts safflower, peach kernel (去皮) 10 parts, 4 parts of centipede, 3 parts of tender deer antler, 1 part of gecko, earth dragon (酒浸) 9 parts, Tu Yuan (制) 9 servings, Eucommia (炒) 12 servings, leeches (酒洗) 7.5 pa...

Embodiment 3

[0021] The medicine of the present invention is mainly made of the following raw materials by weight: Angelica sinensis (酒浸) 12 parts, white ginseng 12 parts, Chuanxiong 15 parts, Chuan Wu (制) 3 servings, Aconitum (制) 3 parts, 8 parts of white poria cocos, 7 parts of angelica dahurica, white snake (沙炒酒浸) 10.5 copies, herb (米泔洗) 6 servings, licorice (蜜灸) 35 servings, silkworm (炒) 10 parts, Liao Asarum 8 parts, Fangfeng 8 parts, Schizonepeta 8 parts, two pointed (酒浸) 5 parts, Ephedra 7 parts, Artemisia benzene 7 parts, Dendrobium (酒洗) 12 servings, whole worm (焙干) 6 parts, Gastrodia 6 parts, Salvia 15 parts, Polygonum multiflorum (黑豆水蒸) 10 parts, 6 parts of Tianqi, 20 parts of Astragalus, 10 parts of Rehmannia glutinosa, 8 parts of Rehmannia glutinosa, 59 parts of red peony root, 7 parts of safflower, peach kernel (去皮) 7 parts, centipede 3 parts, tender antler 4 parts, gecko 3 parts, earth dragon (酒浸) 6 parts, soil yuan (制) 7 copies, Eucommia (炒) 10 parts, leeches (酒洗...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicament for treating cardiovascular and cerebrovascular diseases and apoplexy after-effect, which is prepared from Chinese angelica root, Ligusticum wallichii, Sichuan aconite root, poria cocos, dahurian angelica root, agkistrodon acutus, atractylodes rhizome, licorice root, ledebouriella root, Schizonepeta tenuifolia, shiny pricklyash, Chinese ephedra, Dendrobium nobile, scorpion, gastrodia tuber, root of red rooted saliva, fleece-flower root, astragalus root, prepared rehmannia root, radix paeoniae rubrathe, safflower, centipede, hairy deerhorn, earthworm, dried body of ground beetle, eucommia bark, leeches, cherokee rose, and cyathula root.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicines, and in particular relates to a medicine for treating cardiovascular and cerebrovascular diseases and stroke sequelae. Background technique [0002] Cardiovascular and cerebrovascular diseases refer to a class of diseases caused by emotional injury, lack of endowment, old age and infirmity, long-term illness and lack of support, causing heart and brain dysfunction and pathological changes. , dementia and impotence; stroke is mostly due to fatigue and internal injury, worry and anger, craving for delicious food, qi and blood disorder, imbalance of yin and yang, directly rushing into the brain, resulting in blockage of cerebral vessels or blood overflowing outside the cerebral vessels, and the patient suddenly faints Servant, hemiplegia, slanted mouth and eye sockets, slurred speech, partial body numbness are the main symptoms, which are common and frequently-occurring diseases...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/8988A61P9/00A61P9/10A61P25/00A61K35/64A61K35/62A61K35/58A61K35/56A61K35/32A61K35/583A61K35/646A61K35/648
Inventor 李文杰徐九玲李松伟李松范李晓克任晓辉
Owner 李文杰
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products